Sign in

Publications

Search in 13066 publications:

Reset RSS
Time frame
11585 Publication(s)
Jan 7, 2021
The Lisbon Agreement on femoroacetabular impingement imaging-part 2: general issues, parameters, and reporting
Mascarenhas V, Robinson P, Karantanas A, Sudoł-Szopińska I, Anderson S, Noebauer-Huhmann I, Marin-Peña O, Collado D, Tey-Pons M, Schmaranzer E, Padron M, Kramer J, Zingg P, De Maeseneer M, Jans L, Dietrich T, Vanhoenacker F, Castro M, Afonso P, Rego P, Dienst M, Sutter R, Schmaranzer F, Sconfienza L, Kassarjian A, Ayeni O, Beaulé P, Dantas P, Lalam R, Weber M, Llopis E. The Lisbon Agreement on femoroacetabular impingement imaging-part 2: general issues, parameters, and reporting. Eur Radiol 2021
Jan 7, 2021
The Lisbon Agreement on femoroacetabular impingement imaging-part 2: general issues, parameters, and reporting
Jan 7, 2021

Eur Radiol 2021

Mascarenhas Vasco V, Robinson Philip, Karantanas Apostolos H, Sudoł-Szopińska Iwona, Anderson Suzanne, Noebauer-Huhmann Iris, Marin-Peña Oliver, Collado Diego, Tey-Pons Marc, Schmaranzer Ehrenfried, Padron Mario, Kramer Josef, Zingg Patrick O, De Maeseneer Michel, Jans Lennart, Dietrich Tobias, Vanhoenacker Filip M, Castro Miguel O, Afonso P Diana, Rego Paulo, Dienst Michael, Sutter Reto, Schmaranzer Florian, Sconfienza Luca, Kassarjian Ara, Ayeni Olufemi R, Beaulé Paul E, Dantas Pedro, Lalam Radhesh, Weber Marc-André, Llopis Eva

more
Jan 7, 2021
The Lisbon Agreement on Femoroacetabular Impingement Imaging-part 3: imaging techniques
Castro M, Robinson P, Karantanas A, Sudoł-Szopińska I, Anderson S, Noebauer-Huhmann I, Marin-Peña O, Collado D, Tey-Pons M, Schmaranzer E, Padron M, Kramer J, Zingg P, De Maeseneer M, Jans L, Dietrich T, Vanhoenacker F, Mascarenhas V, Afonso P, Rego P, Schmaranzer F, Sutter R, Kassarjian A, Sconfienza L, Dienst M, Ayeni O, Beaulé P, Dantas P, Lalam R, Weber M, Llopis E. The Lisbon Agreement on Femoroacetabular Impingement Imaging-part 3: imaging techniques. Eur Radiol 2021
Jan 7, 2021
The Lisbon Agreement on Femoroacetabular Impingement Imaging-part 3: imaging techniques
Jan 7, 2021

Eur Radiol 2021

Castro Miguel O, Robinson Philip, Karantanas Apostolos H, Sudoł-Szopińska Iwona, Anderson Suzanne, Noebauer-Huhmann Iris, Marin-Peña Oliver, Collado Diego, Tey-Pons Marc, Schmaranzer Ehrenfried, Padron Mario, Kramer Josef, Zingg Patrick O, De Maeseneer Michel, Jans Lennart, Dietrich Tobias, Vanhoenacker Filip M, Mascarenhas Vasco V, Afonso P Diana, Rego Paulo, Schmaranzer Florian, Sutter Reto, Kassarjian Ara, Sconfienza Luca, Dienst Michael, Ayeni Olufemi R, Beaulé Paul E, Dantas Pedro, Lalam Radhesh, Weber Marc-André, Llopis Eva

more
Jan 7, 2021
Germline BRCA1/2 mutations and severe haematological toxicities in patients with breast cancer treated with neoadjuvant chemotherapy
Furlanetto J, Lederer B, Gerber B, Zahm D, Bauerfeind I, Nekljudova V, Hanusch C, Jackisch C, Link T, Hahnen E, Loibl S, Couch F, Schmutzler R, Möbus V, Schneeweiss A, Rhiem K, Tesch H, Blohmer J, Lübbe K, Untch M, Salat C, Huober J, Klare P, Fasching P. Germline BRCA1/2 mutations and severe haematological toxicities in patients with breast cancer treated with neoadjuvant chemotherapy. Eur J Cancer 2021; 145:44-52.
Jan 7, 2021
Germline BRCA1/2 mutations and severe haematological toxicities in patients with breast cancer treated with neoadjuvant chemotherapy
Jan 7, 2021

Eur J Cancer 2021; 145:44-52

Furlanetto Jenny, Lederer Bianca, Gerber Bernd, Zahm Dirk-Michael, Bauerfeind Ingo, Nekljudova Valentina, Hanusch Claus, Jackisch Christian, Link Theresa, Hahnen Eric, Loibl Sibylle, Couch Fergus J, Schmutzler Rita, Möbus Volker, Schneeweiss Andreas, Rhiem Kerstin, Tesch Hans, Blohmer Jens-Uwe, Lübbe Kristina, Untch Michael, Salat Christoph, Huober Jens, Klare Peter, Fasching Peter A

more
Jan 7, 2021
Trial of Upadacitinib or Abatacept in Rheumatoid Arthritis. Reply
Rubbert-Roth A, Xavier R. Trial of Upadacitinib or Abatacept in Rheumatoid Arthritis. Reply. N Engl J Med 2021; 384:83-84.
Jan 7, 2021
Trial of Upadacitinib or Abatacept in Rheumatoid Arthritis. Reply
Jan 7, 2021

N Engl J Med 2021; 384:83-84

Rubbert-Roth Andrea, Xavier Ricardo M

more
Jan 6, 2021
Pre-transplant Social Adaptability Index and clinical outcomes in renal transplantation - The Swiss Transplant Cohort Study
Denhaerynck K, Goldfarb-Rumyantzev A, Sandhu G, Beckmann S, Huynh-Do U, Binet F, De Geest S, Psychosocial Interest Group, Swiss Transplant Cohort Study. Pre-transplant Social Adaptability Index and clinical outcomes in renal transplantation - The Swiss Transplant Cohort Study. Clin Transplant 2021:e14218.
Jan 6, 2021
Pre-transplant Social Adaptability Index and clinical outcomes in renal transplantation - The Swiss Transplant Cohort Study
Jan 6, 2021

Clin Transplant 2021:e14218

Denhaerynck Kris, Goldfarb-Rumyantzev Alexander S, Sandhu Gurprataap, Beckmann Sonja, Huynh-Do Uyen, Binet Françoise-Isabelle, De Geest Sabina, Psychosocial Interest Group, Swiss Transplant Cohort Study

more
Jan 6, 2021
Metastasis directed stereotactic radiotherapy in NSCLC patients progressing under targeted- or immunotherapy: efficacy and safety reporting from the 'TOaSTT' database
Kroeze S, Eckert F, Lohaus F, Sackerer I, Skazikis G, Geier M, Szuecs M, Glatzer M, Schymalla M, Adebahr S, Verhoeff J, Siva S, Roeder F, Kahl K, Blanck O, Kaul D, Fritz C, Schaule J, Guckenberger M. Metastasis directed stereotactic radiotherapy in NSCLC patients progressing under targeted- or immunotherapy: efficacy and safety reporting from the 'TOaSTT' database. Radiat Oncol 2021; 16:4.
Jan 6, 2021
Metastasis directed stereotactic radiotherapy in NSCLC patients progressing under targeted- or immunotherapy: efficacy and safety reporting from the 'TOaSTT' database
Jan 6, 2021

Radiat Oncol 2021; 16:4

Kroeze Stephanie G C, Eckert Franziska, Lohaus Fabian, Sackerer Irina, Skazikis Georgios, Geier Michael, Szuecs Marcella, Glatzer Markus, Schymalla Markus M, Adebahr Sonja, Verhoeff Joost J C, Siva Shankar, Roeder Falk, Kahl Klaus H, Blanck Oliver, Kaul David, Fritz Corinna, Schaule Jana, Guckenberger Matthias

more
Jan 6, 2021
Characteristics of Three Different Chemiluminescence Assays for Testing for SARS-CoV-2 Antibodies
Weber M, Imperiali M, Salimi Y, Fleisch F, Cusini A, Heer S, Renz H, Paprotny M, Kohler P, Vernazza P, Risch L, Bodmer T, Egli K, Risch M, Thiel S, Grossmann K, Nigg S, Wohlwend N, Lung T, Hillmann D, Ritzler M, Ferrara F, Bigler S, Kahlert C. Characteristics of Three Different Chemiluminescence Assays for Testing for SARS-CoV-2 Antibodies. Dis Markers 2021; 2021:8810196.
Jan 6, 2021
Characteristics of Three Different Chemiluminescence Assays for Testing for SARS-CoV-2 Antibodies
Jan 6, 2021

Dis Markers 2021; 2021:8810196

Weber Myriam C, Imperiali Mauro, Salimi Yacir, Fleisch Felix, Cusini Alexia, Heer Sonja, Renz Harald, Paprotny Matthias, Kohler Philipp, Vernazza Pietro, Risch Lorenz, Bodmer Thomas, Egli Konrad, Risch Martin, Thiel Sarah L, Grossmann Kirsten, Nigg Susanne, Wohlwend Nadia, Lung Thomas, Hillmann Dorothea, Ritzler Michael, Ferrara Francesca, Bigler Susanna, Kahlert Christian

more
Jan 6, 2021
Topical Treatment of Psoriasis Vulgaris: The Swiss Treatment Pathway
Maul J, Dippel M, Yawalkar N, Trüeb R, Schlapbach C, Mainetti C, Lapointe A, Laffitte E, Kolios A, Jalili A, Häusermann P, Cozzio A, Conrad C, Anzengruber F, Navarini A. Topical Treatment of Psoriasis Vulgaris: The Swiss Treatment Pathway. Dermatology 2021; 237:166-178.
Jan 6, 2021
Topical Treatment of Psoriasis Vulgaris: The Swiss Treatment Pathway
Jan 6, 2021

Dermatology 2021; 237:166-178

Maul Julia-Tatjana, Dippel Michaela, Yawalkar Nikhil, Trüeb Ralph, Schlapbach Christoph, Mainetti Carlo, Lapointe Anne-Karine, Laffitte Emmanuel, Kolios Antonios G A, Jalili Ahmad, Häusermann Peter, Cozzio Antonio, Conrad Curdin, Anzengruber Florian, Navarini Alexander A

more
Jan 5, 2021
Post-Tuberculosis Lung Disease: Clinical Review of an Under-Recognised Global Challenge
Allwood B, Byrne A, Meghji J, Rachow A, van der Zalm M, Schoch O. Post-Tuberculosis Lung Disease: Clinical Review of an Under-Recognised Global Challenge. Respiration 2021; 100:751-763.
Jan 5, 2021
Post-Tuberculosis Lung Disease: Clinical Review of an Under-Recognised Global Challenge
Jan 5, 2021

Respiration 2021; 100:751-763

Allwood Brian W, Byrne Anthony, Meghji Jamilah, Rachow Andrea, van der Zalm Marieke M, Schoch Otto

more
Jan 5, 2021
Corrigendum to "Initial experience with CDK4/6 inhibitor-based therapies compared to antihormone monotherapies in routine clinical use in patients with hormone receptor positive, HER2 negative breast cancer - Data from the PRAEGNANT research network for the first 2 years of drug availability in Germany"
Schneeweiss A, Lux M, Müller V, Nabieva N, Overkamp F, Tesch H, Laakmann E, Taran F, Seitz J, Thomssen C, Untch M, Wimberger P, Wuerstlein R, Volz B, Wallwiener D, Wallwiener M, Klein E, Kurbacher C, Ettl J, Luftner D, Beckmann M, Belleville E, Fasching P, Fehm T, Geberth M, Häberle L, Hadji P, Hartkopf A, Hielscher C, Huober J, Ruckhäberle E, Janni W, Kolberg H, Brucker S. Corrigendum to "Initial experience with CDK4/6 inhibitor-based therapies compared to antihormone monotherapies in routine clinical use in patients with hormone receptor positive, HER2 negative breast cancer - Data from the PRAEGNANT research network for the first 2 years of drug availability in Germany". Breast 2021; 55:138-139.
Jan 5, 2021
Corrigendum to "Initial experience with CDK4/6 inhibitor-based therapies compared to antihormone monotherapies in routine clinical use in patients with hormone receptor positive, HER2 negative breast cancer - Data from the PRAEGNANT research network for the first 2 years of drug availability in Germany"
Jan 5, 2021

Breast 2021; 55:138-139

Schneeweiss Andreas, Lux Michael P, Müller Volkmar, Nabieva Naiba, Overkamp Friedrich, Tesch Hans, Laakmann Elena, Taran Florin-Andrei, Seitz Julia, Thomssen Christoph, Untch Michael, Wimberger Pauline, Wuerstlein Rachel, Volz Bernhard, Wallwiener Diethelm, Wallwiener Markus, Klein Evelyn, Kurbacher Christian M, Ettl Johannes, Luftner Diana, Beckmann Matthias W, Belleville Erik, Fasching Peter A, Fehm Tanja N, Geberth Matthias, Häberle Lothar, Hadji Peyman, Hartkopf Andreas D, Hielscher Carsten, Huober Jens, Ruckhäberle Eugen, Janni Wolfgang, Kolberg Hans Christian, Brucker Sara Y

more
Jan 4, 2021
[Celebrations with consequences: fever, dyspnea and chest pain]
Punzet M, Bayer M, Schoch O. [Celebrations with consequences: fever, dyspnea and chest pain]. Dtsch Med Wochenschr 2021; 146:38-40.
Jan 4, 2021
[Celebrations with consequences: fever, dyspnea and chest pain]
Jan 4, 2021

Dtsch Med Wochenschr 2021; 146:38-40

Punzet Marit, Bayer Michael, Schoch Otto

more
Jan 4, 2021
Recombinant human C1 esterase inhibitor (conestat alfa) in the prevention of severe SARS-CoV-2 infection in hospitalized patients with COVID-19: A structured summary of a study protocol for a randomized, parallel-group, open-label, multi-center pilot trial (PROTECT-COVID-19)
Urwyler P, Sendi P, Albrich W, Stüssi-Helbling M, Huber L, Bacci M, Camacho-Ortiz A, Sumer J, Thoma R, Trendelenburg M, Heijnen I, Moser S, Charitos P, Osthoff M. Recombinant human C1 esterase inhibitor (conestat alfa) in the prevention of severe SARS-CoV-2 infection in hospitalized patients with COVID-19: A structured summary of a study protocol for a randomized, parallel-group, open-label, multi-center pilot trial (PROTECT-COVID-19). Trials 2021; 22:1.
Jan 4, 2021
Recombinant human C1 esterase inhibitor (conestat alfa) in the prevention of severe SARS-CoV-2 infection in hospitalized patients with COVID-19: A structured summary of a study protocol for a randomized, parallel-group, open-label, multi-center pilot trial (PROTECT-COVID-19)
Jan 4, 2021

Trials 2021; 22:1

Urwyler Pascal, Sendi Parham, Albrich Werner, Stüssi-Helbling Melina, Huber Lars C, Bacci Marcelo R, Camacho-Ortiz Adrián, Sumer Johannes, Thoma Reto, Trendelenburg Marten, Heijnen Ingmar A F M, Moser Stephan, Charitos Panteleimon, Osthoff Michael

more
Jan 3, 2021
PPARγ is essential for the development of bone marrow erythroblastic island macrophages and splenic red pulp macrophages
Okreglicka K, Schneider C, Nielsen P, Ludewig B, Kurrer M, Feng Q, Onder L, Pohlmeier L, Iten I, Kopf M. PPARγ is essential for the development of bone marrow erythroblastic island macrophages and splenic red pulp macrophages. J Exp Med 2021; 218
Jan 3, 2021
PPARγ is essential for the development of bone marrow erythroblastic island macrophages and splenic red pulp macrophages
Jan 3, 2021

J Exp Med 2021; 218

Okreglicka Katarzyna, Schneider Christoph, Nielsen Peter, Ludewig Burkhard, Kurrer Michael, Feng Qian, Onder Lucas, Pohlmeier Lea, Iten Irina, Kopf Manfred

more
Jan 3, 2021
Primary Localized Giant Adrenal Cortical Carcinoma in a Young Adult Woman
Sortino R, Schmid M, Benigno L, Kolb W. Primary Localized Giant Adrenal Cortical Carcinoma in a Young Adult Woman. Clinical Images and Case Reports Journal 2021; 3:134.
Jan 3, 2021
Primary Localized Giant Adrenal Cortical Carcinoma in a Young Adult Woman
Jan 3, 2021

Clinical Images and Case Reports Journal 2021; 3:134

Sortino Rosita, Schmid Michael, Benigno Luca, Kolb Walter

more
Jan 3, 2021
Rituximab plus leflunomide in rheumatoid arthritis: a randomized, placebo-controlled, investigator-initiated clinical trial (AMARA study)
Behrens F, Wassenberg S, Tony H, Rubbert-Roth A, Müller-Ladner U, Lehn A, Krueger K, Kellner H, Herrmann E, Feist E, Burmester G, Backhaus M, Aringer M, Alten R, Rossmanith T, Koehm M, Burkhardt H. Rituximab plus leflunomide in rheumatoid arthritis: a randomized, placebo-controlled, investigator-initiated clinical trial (AMARA study). Rheumatology (Oxford) 2021; 60:5318-5328.
Jan 3, 2021
Rituximab plus leflunomide in rheumatoid arthritis: a randomized, placebo-controlled, investigator-initiated clinical trial (AMARA study)
Jan 3, 2021

Rheumatology (Oxford) 2021; 60:5318-5328

Behrens Frank, Wassenberg Siegfried, Tony Hans-Peter, Rubbert-Roth Andrea, Müller-Ladner Ulf, Lehn Annette, Krueger Klaus, Kellner Herbert, Herrmann Eva, Feist Eugen, Burmester Gerd R, Backhaus Marina, Aringer Martin, Alten Rieke, Rossmanith Tanja, Koehm Michaela, Burkhardt Harald

more
Jan 3, 2021
Clinical Images: Hydroxychloroquine-associated mucous labial pigmentation in a patient with systemic lupus erythematosus improving under topical treatment with tacrolimus
Pirker I, Saulite I, von Kempis J. Clinical Images: Hydroxychloroquine-associated mucous labial pigmentation in a patient with systemic lupus erythematosus improving under topical treatment with tacrolimus. ACR Open Rheumatol 2021; 3:41.
Jan 3, 2021
Clinical Images: Hydroxychloroquine-associated mucous labial pigmentation in a patient with systemic lupus erythematosus improving under topical treatment with tacrolimus
Jan 3, 2021

ACR Open Rheumatol 2021; 3:41

Pirker Ian, Saulite Ieva, von Kempis Johannes

more
Jan 2, 2021
Coronary Artery Disease-Associated and Longevity-Associated Polygenic Risk Scores for Prediction of Coronary Artery Disease Events in Persons Living With Human Immunodeficiency Virus: The Swiss HIV Cohort Study
Schoepf I, Tarr P, Fellay J, Günthard H, Kouyos R, Buvelot H, Cavassini M, Bernasconi E, Seneghini M, Thurnheer C, Marzolini C, Hasse B, Reiss P, Kootstra N, Raffenberg M, Engel T, Ledergerber B, Thorball C, Swiss HIV Cohort Study. Coronary Artery Disease-Associated and Longevity-Associated Polygenic Risk Scores for Prediction of Coronary Artery Disease Events in Persons Living With Human Immunodeficiency Virus: The Swiss HIV Cohort Study. Clin Infect Dis 2021; 73:1597-1604.
Jan 2, 2021
Coronary Artery Disease-Associated and Longevity-Associated Polygenic Risk Scores for Prediction of Coronary Artery Disease Events in Persons Living With Human Immunodeficiency Virus: The Swiss HIV Cohort Study
Jan 2, 2021

Clin Infect Dis 2021; 73:1597-1604

Schoepf Isabella C, Tarr Philip E, Fellay Jacques, Günthard Huldrych F, Kouyos Roger, Buvelot Hélène, Cavassini Matthias, Bernasconi Enos, Seneghini Marco, Thurnheer Christine, Marzolini Catia, Hasse Barbara, Reiss Peter, Kootstra Neeltje A, Raffenberg Marieke, Engel Tanja, Ledergerber Bruno, Thorball Christian W, Swiss HIV Cohort Study

more
Jan 2, 2021
Severe Coronavirus Disease 2019 (COVID-19) is Associated With Elevated Serum Immunoglobulin (Ig) A and Antiphospholipid IgA Antibodies
Hasan Ali O, Penninger J, Bergthaler A, Popa A, Gómez-Mejia A, Schüpbach R, Bühler P, Vernazza P, Kahlert C, Kohler P, Albrich W, Kern L, Thiel S, Weber M, Paprotny M, Brugger S, Risch L, Bomze D, Flatz L. Severe Coronavirus Disease 2019 (COVID-19) is Associated With Elevated Serum Immunoglobulin (Ig) A and Antiphospholipid IgA Antibodies. Clin Infect Dis 2021; 73:e2869-e2874.
Jan 2, 2021
Severe Coronavirus Disease 2019 (COVID-19) is Associated With Elevated Serum Immunoglobulin (Ig) A and Antiphospholipid IgA Antibodies
Jan 2, 2021

Clin Infect Dis 2021; 73:e2869-e2874

Hasan Ali Omar, Penninger Josef M, Bergthaler Andreas, Popa Alexandra M, Gómez-Mejia Alejandro, Schüpbach Reto A, Bühler Philipp K, Vernazza Pietro, Kahlert Christian, Kohler Philipp, Albrich Werner, Kern Lukas, Thiel Sarah, Weber Myriam, Paprotny Matthias, Brugger Silvio D, Risch Lorenz, Bomze David, Flatz Lukas

more
Jan 2, 2021
Associations between serum antibodies to periodontal pathogens and preclinical phases of rheumatoid arthritis
Manoil D, Courvoisier D, Gilbert B, Möller B, Walker U, Muehlenen I, Rubbert-Roth A, Finckh A, Bostanci N. Associations between serum antibodies to periodontal pathogens and preclinical phases of rheumatoid arthritis. Rheumatology (Oxford) 2021; 60:4755-4764.
Jan 2, 2021
Associations between serum antibodies to periodontal pathogens and preclinical phases of rheumatoid arthritis
Jan 2, 2021

Rheumatology (Oxford) 2021; 60:4755-4764

Manoil Daniel, Courvoisier Delphine S, Gilbert Benoit, Möller Burkhard, Walker Ulrich A, Muehlenen Ines Von, Rubbert-Roth Andrea, Finckh Axel, Bostanci Nagihan

more
Jan 1, 2021
Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group
Richardson P, Goldschmidt H, Harousseau J, Dytfeld D, Mellqvist U, Chng W, Hou J, Bergsagel P, Riva E, Leleu X, Bladé J, Driessen C, Quach H, Ocio E, Vesole D, Waage A, Laubach J, Munshi N, Gay F, Dimopoulos M, Rajkumar S, Mateos M, Cook G, Nahi H, Harrison S, Sezer O, Holstein S, Zweegman S, Usmani S, Boccadoro M, Hari P, Kaiser M, Costa L, Beksac M, Maiolino A, Leal da Costa F, Sidana S, Jurczyszyn A, Facon T, Durie B, Yong K, Martin T, Schjesvold F, Terpos E, Mikhael J, Ludwig H, Bahlis N, Zamagni E, Davies F, San Miguel J, Kumar S, Raje N, van de Donk N, Lonial S, Berdeja J, Hungria V, Baz R, Weisel K, Vangsted A, Fonseca R, Engelhardt M, Sonneveld P, Einsele H, João C, Anderson K, Hájek R, Lentzsch S, Kristinsson S, Cavo M, Moreau P. Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group. Lancet Oncol 2021; 22:e105-e118.
Jan 1, 2021
Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group
Jan 1, 2021

Lancet Oncol 2021; 22:e105-e118

Richardson Paul G, Goldschmidt Hartmut, Harousseau Jean-Luc, Dytfeld Dominik, Mellqvist Ulf-Henrik, Chng Wee Joo, Hou Jian, Bergsagel Peter Leif, Riva Eloisa, Leleu Xavier, Bladé Joan, Driessen Christoph, Quach Hang, Ocio Enrique M, Vesole David H, Waage Anders, Laubach Jacob, Munshi Nikhil C, Gay Francesca, Dimopoulos Meletios A, Rajkumar S Vincent, Mateos Maria-Victoria, Cook Gordon, Nahi Hareth, Harrison Simon, Sezer Orhan, Holstein Sarah, Zweegman Sonja, Usmani Saad Z, Boccadoro Mario, Hari Parameswaran, Kaiser Martin, Costa Luciano J, Beksac Meral, Maiolino Angelo, Leal da Costa Fernando, Sidana Surbhi, Jurczyszyn Artur, Facon Thierry, Durie Brian G M, Yong Kwee, Martin Thomas, Schjesvold Fredrik, Terpos Evangelos, Mikhael Joseph, Ludwig Heinz, Bahlis Nizar, Zamagni Elena, Davies Faith, San Miguel Jesús, Kumar Shaji K, Raje Noopur, van de Donk Niels, Lonial Sagar, Berdeja Jesus G, Hungria Vania, Baz Rachid, Weisel Katja, Vangsted Annette, Fonseca Rafael, Engelhardt Monika, Sonneveld Pieter, Einsele Hermann, João Cristina, Anderson Kenneth C, Hájek Roman, Lentzsch Suzanne, Kristinsson Sigurdur Y, Cavo Michele, Moreau Philippe

more

We use cookies and tracking technologies according to our privacy policy to provide you with the best possible web experience. To the privacy policy